ArticleCancer research2018

Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.

Jason P W Carey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.